Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Ching Hua Lin |
Documentos disponibles escritos por este autor (2)
Refinar búsqueda
Early prediction of fluoxetine response for han chinese inpatients with major depressive disorder / Ching Hua Lin en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 2 (Abril)
[artículo]
Título : Early prediction of fluoxetine response for han chinese inpatients with major depressive disorder Tipo de documento: texto impreso Autores: Ching Hua Lin, Autor ; Hsien Yuan Lane, Autor ; Cheng Chung Chen, Autor Fecha de publicación: 2022 Artículo en la página: pp. 187-193 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Fluoxetina, Modelo de predicción temprana Resumen: The onset of antidepressant action is vital clinically. This study aimed to testify whether early symptom improvement can predict eventual treatment response at week 6 among depressive hospitalized patients taking fluoxetine. One hundred thirty-one hospitalized patients with major depressive disorder received 20 mg/d of fluoxetine for 6 weeks. Link: ./index.php?lvl=notice_display&id=29395
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 187-193[artículo] Early prediction of fluoxetine response for han chinese inpatients with major depressive disorder [texto impreso] / Ching Hua Lin, Autor ; Hsien Yuan Lane, Autor ; Cheng Chung Chen, Autor . - 2022 . - pp. 187-193.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 187-193
Palabras clave: Trastorno depresivo mayor, Fluoxetina, Modelo de predicción temprana Resumen: The onset of antidepressant action is vital clinically. This study aimed to testify whether early symptom improvement can predict eventual treatment response at week 6 among depressive hospitalized patients taking fluoxetine. One hundred thirty-one hospitalized patients with major depressive disorder received 20 mg/d of fluoxetine for 6 weeks. Link: ./index.php?lvl=notice_display&id=29395 A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia / Ching Hua Lin en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)
[artículo]
Título : A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia Tipo de documento: texto impreso Autores: Ching Hua Lin, Autor ; Chao Chan Kuo, Autor ; Li Shiu Chou, Autor Fecha de publicación: 2022 Artículo en la página: pp. 518-525 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Combinación de fármacos antipsicóticos, Esquizofrenia, Haloperidol, Risperidona Resumen: Monotherapy is recommended for schizophrenia treatment, but the risk-benefit issue of antipsychotic drug combination (except for clozapine) remains unclear. Risperidone, an atypical antipsychotic drug, has a lower incidence of extrapyramidal syndrome but higher risks of prolactinemia and metabolic syndrome than haloperidol, a typical agent. Link: ./index.php?lvl=notice_display&id=29424
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 518-525[artículo] A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia [texto impreso] / Ching Hua Lin, Autor ; Chao Chan Kuo, Autor ; Li Shiu Chou, Autor . - 2022 . - pp. 518-525.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 518-525
Palabras clave: Combinación de fármacos antipsicóticos, Esquizofrenia, Haloperidol, Risperidona Resumen: Monotherapy is recommended for schizophrenia treatment, but the risk-benefit issue of antipsychotic drug combination (except for clozapine) remains unclear. Risperidone, an atypical antipsychotic drug, has a lower incidence of extrapyramidal syndrome but higher risks of prolactinemia and metabolic syndrome than haloperidol, a typical agent. Link: ./index.php?lvl=notice_display&id=29424